Katherine Liau
- Oncology top 2%
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 2%
- Cancer Research top 5%
- Endocrinology, Diabetes and Metabolism top 5%
- Co-authors
- Paul BycottSinil KimOlivier RixeEverett E. VokesDavid R. ShalinskyPeter C. TraskRoger B. CohenEzra E.W. Cohen
- Topics
- Cancer Treatment and Pharmacology (10 papers)Lung Cancer Treatments and Mutations (10 papers)Renal cell carcinoma treatment (8 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Katherine Liau
35 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 1.1k
- Molecular Biology 861
- Pulmonary and Respiratory Medicine 843
- Cancer Research 441
- Endocrinology, Diabetes and Metabolism 390
Countries citing papers authored by Katherine Liau
This map shows the geographic impact of Katherine Liau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Liau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Liau more than expected).
Fields of papers citing papers by Katherine Liau
This network shows the impact of papers produced by Katherine Liau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Liau. The network helps show where Katherine Liau may publish in the future.
Co-authorship network of co-authors of Katherine Liau
This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Liau. A scholar is included among the top collaborators of Katherine Liau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Liau. Katherine Liau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 9 | |
| 3 | 38 | |
| 4 | 38 | |
| 5 | 3 | |
| 6 | 2 | |
| 7 | 93 | |
| 8 | 94 | |
| 9 | 41 | |
| 10 | Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Studybreakdown → | 494 |
| 11 | 204 | |
| 12 | 18 | |
| 13 | Axitinib (AG-013736; AG) in combination with paclitaxel (P)/carboplatin (C) in patients (pts) with advanced solid tumors | 1 |
| 14 | 356 | |
| 15 | 1 | |
| 16 | 14 | |
| 17 | 1 | |
| 18 | 35 | |
| 19 | 12 | |
| 20 | 7 |
About Katherine Liau
Katherine Liau is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 36 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Lung Cancer Treatments and Mutations (10 papers) and Renal cell carcinoma treatment (8 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (441 citations) and Pulmonary and Respiratory Medicine (843 citations). Katherine Liau has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Paul Bycott, Sinil Kim, Olivier Rixe, Everett E. Vokes, David R. Shalinsky, Peter C. Trask, Roger B. Cohen, Ezra E.W. Cohen, Lee S. Rosen and Madeleine Kane. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.